![Thomas L. Wegman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas L. Wegman
Plus aucun poste en cours
Profil
Thomas L.
Wegman served as the President, CEO & Principal Financial Officer of BioSpecifics Technologies Corp.
from 2013 to 2019.
Prior to that, he worked at BioSpecifics Technologies Corp.
from 1994 to 2019.
He also served as Co-Trustee at Edwin H Wegman Marital Trust.
Wegman received his undergraduate degree from Boston University in 1977.
Anciens postes connus de Thomas L. Wegman
Sociétés | Poste | Fin |
---|---|---|
BIOSPECIFICS TECHNOLOGIES CORP. | Directeur Général | 13/03/2019 |
Edwin H Wegman Marital Trust
![]() Edwin H Wegman Marital Trust Investment Trusts/Mutual FundsMiscellaneous Edwin H Wegman Marital Trust provides trust services. The private company is based in Lynbrook. | Directeur/Membre du Conseil | 13/03/2019 |
Formation de Thomas L. Wegman
Boston University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
BioSpecifics Technologies Corp.
![]() BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
Edwin H Wegman Marital Trust
![]() Edwin H Wegman Marital Trust Investment Trusts/Mutual FundsMiscellaneous Edwin H Wegman Marital Trust provides trust services. The private company is based in Lynbrook. | Miscellaneous |